NLRP3 and cancer: The compounds polyphyllin VI and 17β-estradiol have been shown to activate NLRP3 in cancer cells, inducing pyroptosis and improving the anti-tumoral immune response in NSCLC and hepatocellular carcinoma [192,197,198].